Status:

ACTIVE_NOT_RECRUITING

Effects of Yeast Beta-glucan on Cognitive Function in Patients With Mild Cognitive Impairment

Lead Sponsor:

Xiaofan Xu

Conditions:

Mild Cognitive Impairment

Alzheimer Disease

Eligibility:

All Genders

50-80 years

Phase:

NA

Brief Summary

Patients with mild cognitive impairment aged 50-80 years old were recruited in Shiyan City, Hubei Province, and divided into intervention group and placebo group. They were given yeast β-glucan capsul...

Eligibility Criteria

Inclusion

  • 1\. Aged 50-80 years;
  • 2\. Permanent residents of Shiyan City;
  • 3\. Meet the diagnostic criteria of MCI:
  • 4\. Willing to cooperate in completing questionnaire survey and clinical examination, and sign informed consent;
  • 5\. Did not participate in other clinical trials in the past 3 months.

Exclusion

  • 1\. Alcohol or drug abuse;
  • 2\. Patients with neurological diseases that may cause cognitive dysfunction, including cerebrovascular diseases, stroke, brain tumors, Parkinson's disease, active epilepsy, etc.;
  • 3\. History of severe head trauma;
  • 4\. Severe sensory and perceptual impairment, unable to complete the cognitive function measurement;
  • 5\. History of mental illness such as depression, mania, anxiety, or take psychiatric drugs;
  • 6\. Serious heart, lung, liver, kidney dysfunction, malignant tumors, etc.;
  • 7\. Suffering from autoimmune diseases;
  • 8\. Trauma, spinal injury or any disease that may affect the motor function of the limb;
  • 9\. Recent infectious diseases, acute gastrointestinal diseases;
  • 10\. Take antibiotics, probiotics, prebiotics or biostime products within the last 1 month.

Key Trial Info

Start Date :

June 27 2023

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

June 30 2025

Estimated Enrollment :

144 Patients enrolled

Trial Details

Trial ID

NCT06083350

Start Date

June 27 2023

End Date

June 30 2025

Last Update

May 14 2024

Active Locations (2)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (2 locations)

1

Sinopharm Dongfeng General Hospital

Shiyan, Hubei, China, 442000

2

Huazhong University of Science and Technology

Wuhan, Hubei, China, 430000